UM: Medical

Science Daily has a story about a needleless hepatitis B vaccine developed at UM’s Michigan Nanotechnology Institute for Medicine and Biological Sciences and licensed to Ann Arbor-based NanoBio Corp.  The vaccine holds special promise for impoverished nations where the need to refrigerate current vaccines and to keep needles sterile is cost-prohibitive. [Source]